Omeros (NASDAQ:OMER) closes its public offering of 3M shares of common stock at $22.75 per shares. Net proceeds of ~$63.6M will be used for general corporate purposes.
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that on August 18, 2017, as scheduled, it closed the underwritten public offering that was priced on August 14, 2017, relating to the sale of …
Omeros Corp. wants to raise about $70 million in a public stock sale. The Seattle biopharmaceutical firm said it plans to use the money for general corporate …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing …
Shares of Omeros Corp. OMER, -7.94% sank 8% in morning trade Tuesday, after the biopharmaceutical company took advantage of a recent surge in price to launch a public offering of shares. The company said late Monday that it was …
The Omeros Corporation, one of Seattle’s biggest biotech companies, is looking …
** Drugmaker's shares down 8.2 pct at $22.60 premarket ** Co prices its follow-on of 3 mln shares at $22.75, a 7.6 pct discount to stock's Mon close ** Offering size represents about 6.7 pct of co's 44.4 mln shares outstanding as of Jun …
SEATTLE--(EON: Enhanced Online News)--Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, …
If you want a Stock Review on OCUL, OMER, OVAS, or RGLS then come over to http://dailystocktracker.com/register …
Omeros Corp. (OMER) announced after the bell Monday that it has commenced a registered underwritten public offering of 3,000,000 shares of its common stock. The stock is now down 1.13 on 24K shares. Omeros climbed during the middle …